inspiremd.com - חוב מצטבר של החברה NSPR

The debt profile demonstrates the dynamics of obligations, where 0.00 serves as the current parameter value. InspireMD, Inc. (NSPR) is developing CGuard stents to combat strokes, focusing on expansion within the US. The strategy relies on training surgeons and clinics in carotid artery treatment methods. A narrow business profile is offset by the uniqueness of the technologies and regulatory approvals across various regions.

This metric aggregates all short-term and long-term credit obligations, allowing for an assessment of financial stability and default risk through the lens of total borrowed capital. By analyzing debt dynamics, an investor determines the ability of InspireMD, Inc. (NSPR) to finance the expansion of the CGuard EPS system and the broadening of distribution in the US and Europe without imposing a critical debt burden on operating activities.